Haleon PLC (HLN) - Total Liabilities

Latest as of June 2025: GBX15.83 Billion GBX ≈ $1.93 Million USD

Based on the latest financial reports, Haleon PLC (HLN) has total liabilities worth GBX15.83 Billion GBX (≈ $1.93 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Haleon PLC - Total Liabilities Trend (2019–2024)

This chart illustrates how Haleon PLC's total liabilities have evolved over time, based on quarterly financial data. See Haleon PLC working capital to net assets to evaluate short-term liquidity relative to the company's equity base.

Haleon PLC Competitors by Total Liabilities

The table below lists competitors of Haleon PLC ranked by their total liabilities.

Company Country Total Liabilities
Lontrue Co Ltd
SHE:300175
China CN¥56.18 Million
Hotel Majestic Cannes
PA:MLHMC
France €33.61 Million
Shandong Minhe Animal Husbandry Co Ltd
SHE:002234
China CN¥1.90 Billion
Reckitt Benckiser Group PLC
LSE:RKT
UK GBX17.29 Billion
Viking Line Abp
HE:VIK1V
Finland €277.00 Million
Southern States Bancshares Inc
NASDAQ:SSBK
USA $2.56 Billion
Shandong Sinobioway Biomedicine Co Ltd
SHE:002581
China CN¥221.51 Million
HPF Co Ltd
SHE:300350
China CN¥412.59 Million

Liability Composition Analysis (2019–2024)

This chart breaks down Haleon PLC's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see HLN company net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 0.87 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.99 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.50 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Haleon PLC's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Haleon PLC (2019–2024)

The table below shows the annual total liabilities of Haleon PLC from 2019 to 2024.

Year Total Liabilities Change
2024-12-31 GBX18.09 Billion
≈ $2.20 Million
+4.42%
2023-12-31 GBX17.33 Billion
≈ $2.11 Million
-5.62%
2022-12-31 GBX18.36 Billion
≈ $2.23 Million
+130.31%
2021-12-31 GBX7.97 Billion
≈ $969.84K
+0.81%
2020-12-31 GBX7.91 Billion
≈ $962.05K
-4.72%
2019-12-31 GBX8.30 Billion
≈ $1.01 Million
--

About Haleon PLC

LSE:HLN UK Drug Manufacturers - Specialty & Generic
Market Cap
$361.16 Million
GBX2.97 Trillion GBX
Market Cap Rank
#14071 Global
#67 in UK
Share Price
GBX333.30
Change (1 day)
-0.54%
52-Week Range
GBX320.90 - GBX410.90
All Time High
GBX415.20
About

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Aquafresh, and Biotene… Read more